Sean N. Tucker

2.7k citations

31 papers · 1.8k indexed · 1 hit paper · h-index 16

Co-authors: Christopher Wilson Heidi K. Jessup Jeff H. Tsai Sophie M. Lehar William M. Weaver Sara Cherry Peggy P. Lee David Fitzpatrick
Topics: Viral gastroenteritis research and epidemiology (13 papers)Virus-based gene therapy research (10 papers)Respiratory viral infections research (10 papers)
Cited by: Immunology Infectious Diseases Molecular Biology
Journals: Blood Immunity Scientific Reports
Partner nations: United States Ireland Australia

In The Last Decade

Sean N. Tucker

31 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Critical Role for Dnmt1 and DNA Methylation in T Cell Development, Function, and Survival

2001 1.0k citations Sean N. Tucker et al. profile →

Peers

Countries citing papers authored by Sean N. Tucker

Since Specialization

Citations

This map shows the geographic impact of Sean N. Tucker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sean N. Tucker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sean N. Tucker more than expected).

Fields of papers citing papers by Sean N. Tucker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sean N. Tucker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sean N. Tucker. The network helps show where Sean N. Tucker may publish in the future.

Co-authorship network of co-authors of Sean N. Tucker

This figure shows the co-authorship network connecting the top 25 collaborators of Sean N. Tucker. A scholar is included among the top collaborators of Sean N. Tucker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sean N. Tucker. Sean N. Tucker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An oral norovirus vaccine generates mucosal immunity and reduces viral shedding in a phase 2 placebo-controlled challenge study 2025 ·Science Translational Medicine ·Becca A. Flitter,Joshua Gillard,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Marcela F. Pasetti,(unknown),(unknown),Robert W. Frenck,Lisa C. Lindesmith,Ralph S. Baric,Lee‐Jen Wei,Sean N. Tucker,James F. Cummings	2
2	An oral norovirus vaccine tablet was safe and elicited mucosal immunity in older adults in a phase 1b clinical trial 2025 ·Science Translational Medicine ·Becca A. Flitter,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Molly R. Braun,Marcela F. Pasetti,Sean N. Tucker,James F. Cummings	5
3	Elimination of Human Papillomavirus 16-Positive Tumors by a Mucosal rAd5 Therapeutic Vaccination in a Pre-Clinical Murine Study 2024 ·Vaccines ·Molly R. Braun,Anne Moore,Jonathan D. Lindbloom,(unknown),Emery G. Dora,Sean N. Tucker	1
4	A Next-Generation Adenoviral Vaccine Elicits Mucosal and Systemic Immunogenicity and Reduces Viral Shedding after SARS-CoV-2 Challenge in Nonhuman Primates 2024 ·Vaccines ·(unknown),(unknown),(unknown),Emery G. Dora,(unknown),Molly R. Braun,Sean N. Tucker,Becca A. Flitter	1
5	Design and validation of an exposure system for efficient inter-animal SARS-CoV-2 airborne transmission in Syrian hamsters 2023 ·Microbiology Spectrum ·Philip J. Kuehl,(unknown),Adam D. Werts,(unknown),Hammad Irshad,Edward G. Barrett,Sean N. Tucker,Stephanie N. Langel	3
6	An easy pill to swallow: oral recombinant vaccines for the 21st century 2023 ·Current Opinion in Immunology ·Molly R. Braun,Becca A. Flitter,William Sun,Sean N. Tucker	6
7	Mucosal immunization with Ad5-based vaccines protects Syrian hamsters from challenge with omicron and delta variants of SARS-CoV-2 2023 ·Frontiers in Immunology ·Molly R. Braun,(unknown),Emery G. Dora,(unknown),(unknown),Sean N. Tucker	7
8	Adenovirus type 5 SARS-CoV-2 vaccines delivered orally or intranasally reduced disease severity and transmission in a hamster model 2022 ·Science Translational Medicine ·Stephanie N. Langel,Susan Johnson,(unknown),(unknown),(unknown),Emery G. Dora,Philip J. Kuehl,Hammad Irshad,Edward G. Barrett,Adam D. Werts,Sean N. Tucker	74
9	Human influenza virus challenge identifies cellular correlates of protection for oral vaccination 2021 ·Cell Host & Microbe ·David R. McIlwain,Han Chen,(unknown),(unknown),Sizun Jiang,Zach B. Bjornson,Nikita Kolhatkar,(unknown),Brice Gaudillière,Julien Hédou,Nilanjan Mukherjee,Christian M. Schürch,Angelica Trejo,Melton B. Affrime,(unknown),Kenneth H. Kim,David Liebowitz,Nima Aghaeepour,Sean N. Tucker,Garry P. Nolan	23
10	Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study 2020 ·The Lancet Infectious Diseases ·David Liebowitz,Keith Gottlieb,Nikita Kolhatkar,Shaily Garg,Jason Asher,(unknown),Kenneth H. Kim,David R. McIlwain,Sean N. Tucker	87
11	An adjuvanted adenovirus 5-based vaccine elicits neutralizing antibodies and protects mice against chikungunya virus-induced footpad swelling 2019 ·Vaccine ·Emery G. Dora,Shannan L. Rossi,Scott C. Weaver,Sean N. Tucker,Roberto Mateo	17
12	Safety and immunogenicity of an oral tablet norovirus vaccine, a phase I randomized, placebo-controlled trial 2018 ·JCI Insight ·Leesun Kim,David Liebowitz,(unknown),(unknown),Marcela F. Pasetti,Shaily Garg,Keith Gottlieb,(unknown),Sean N. Tucker	100
13	Orally administered adenoviral-based vaccine induces respiratory mucosal memory and protection against RSV infection in cotton rats 2018 ·Vaccine ·(unknown),Ciaran D. Scallan,Roberto Mateo,Robert B. Belshe,Sean N. Tucker,Anne Moore	21
14	Systemic and mucosal immune responses following oral adenoviral delivery of influenza vaccine to the human intestine by radio controlled capsule 2016 ·Scientific Reports ·Leesun Kim,(unknown),(unknown),(unknown),(unknown),Erik P. Sandefer,W Döll,(unknown),Sean N. Tucker	41
15	High titre neutralising antibodies to influenza after oral tablet immunisation: a phase 1, randomised, placebo-controlled trial 2015 ·The Lancet Infectious Diseases ·David Liebowitz,Jonathan D. Lindbloom,(unknown),Shaily Garg,Sean N. Tucker	66
16	An Adenovirus-Based Vaccine with a Double-Stranded RNA Adjuvant Protects Mice and Ferrets against H5N1 Avian Influenza in Oral Delivery Models 2012 ·Clinical and Vaccine Immunology ·Ciaran D. Scallan,(unknown),Jonathan D. Lindbloom,(unknown),Sean N. Tucker	57
17	Salivary gland genetic vaccination: a scalable technology for promoting distal mucosal immunity and heightened systemic immune responses 2004 ·Vaccine ·Sean N. Tucker,(unknown),(unknown),Roland Scollay,Malcolm J. Bennett,David C. Olson	11
18	Systemic and mucosal antibody responses following retroductal gene transfer to the salivary gland 2003 ·Molecular Therapy ·Sean N. Tucker,(unknown),(unknown),Roland Scollay,Malcolm J. Bennett,David C. Olson	19
19	Examination of primary metabolic pathways in a murine hybridoma with carbon‐13 nuclear magnetic resonance spectroscopy 1994 ·Biotechnology and Bioengineering ·Anthony Mancuso,Susan T. Sharfstein,Sean N. Tucker,Douglas S. Clark,Harvey W. Blanch	73
20	Quantitative in vivo nuclear magnetic resonance studies of hybridoma metabolism 1994 ·Biotechnology and Bioengineering ·Susan T. Sharfstein,Sean N. Tucker,Anthony Mancuso,Harvey W. Blanch,Douglas S. Clark	64

About Sean N. Tucker

Sean N. Tucker is a scholar working on Infectious Diseases, Animal Science and Zoology and Genetics, having authored 31 papers that have together received 1.8k indexed citations. Recurring topics across this work include Viral gastroenteritis research and epidemiology (13 papers), Virus-based gene therapy research (10 papers) and Respiratory viral infections research (10 papers). The work is most often cited by research in Immunology (864 citations), Infectious Diseases (496 citations) and Molecular Biology (720 citations). Sean N. Tucker has collaborated with scholars based in United States, Ireland and Australia. Frequent co-authors include Christopher Wilson, Heidi K. Jessup, Jeff H. Tsai, Sophie M. Lehar, William M. Weaver, Sara Cherry, Peggy P. Lee, David Fitzpatrick, Karen W. Makar and Marianne T. Sweetser. Their work appears in journals such as Blood, Immunity and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact